Fertility centres will improve their clinical workflow, provide higher quality services at lower costs
Paeon provides fertility centres with two cloud-based software services: Treatment Decision Support System (TDSS) and Estradiol Estimation (E2E).
By exploiting these services in their clinical practice, fertility centres can improve on their clinical worksflow and providing higher quality, personalised health care at lower costs.
TDSS supports physicians in the daily administration of treatment protocols.
On the basis of the protocol to be followed and actual patient clinical data, TDSS suggests actions to be performed, as timing and amount of drugs to be administered as well as the day of the next visit.
TDSS allows teams of physicians to define portfolios of treatment protocols to use and enables their consistent administration by team members.
Actual fertility treatments currently in use at the Division of Reproductive Endocrinology of University Hospital Zurich have been successfully defined and made available within TDSS.
Treatment protocols defined in TDSS go much beyond usual clinical guidelines. They precisely encode the strategy to follow on the basis on patient data, as external factors (for example, age) and clinical measurements (for example, as for fertility treatments, antral follicle count and hormone blood levels).
TDSS monitors treatments on actual patients and stores physician decisions and deviations with respect to defined protocol, enabling ex-post analyses and discovery of better strategies.
By suggesting clinical actions according to the protocol to be followed, TDSS allows new physicians to be quickly able to properly administering treatment protocols defined within the system, under remote control by supervisors.
TDSS enables fertility centres to foster networking by sharing successful treatment protocols with partner clinics in an intellectual property protecting environment.
Like all software services developed within Paeon, TDSS is not restricted to fertility treatments, as it is ready to be used with other treatment protocols using different drugs and relying on different patient clinical data.
Keeping blood Estradiol level under control is crucial during fertility treatments in order to avoid risk of overstimulation. To this end blood samples are typically taken every one or two days.
As during fertility treatments Estradiol is mainly produced by the growing follicles, E2E allows physicians to estimate Estradiol level from number and size of the growing follicles as a result of transvaginal ultrasounds.
E2E enables reduction of the number of required blood samples during treatment to check that Estradiol level is below its safety threshold.
This contributes to reduce costs of fertility treatments.
As patients can perform transvaginal ultrasounds by themselves at home with portable devices (see for example Sonaura), E2E allows remote Estradiol estimation, thus enabling reduction of the number of patient visits per treatment.
This also contributes to reduce costs of fertility treatments and to increase patient comfort.
E2E computes reliable individualised Estradiol estimations by taking into account patient external factors (for example, AFC, pathologies, treatment protocol in use).
Accuracy improves after any actual measurement. For most patient groups two measurements suffice to have fully reliable estimations.
